Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1973 Feb;52(2):406–413. doi: 10.1172/JCI107197

Escherichia Coli Bacteremia in the Squirrel Monkey I. EFFECT OF COBRA VENOM FACTOR TREATMENT

David N Gilbert 1, Jack A Barnett 1, Jay P Sanford 1
PMCID: PMC302270  PMID: 4630602

Abstract

Squirrel monkeys were significantly depleted of complement by a nontoxic protein constituent of cobra venom, and the influence of cobra factor (CoF) treatment on the course of Escherichia coli bacteremia was studied. Striking neutropenia occurred rapidly in control animals while the rate of occurrence of neutropenia was 20 to 30 times slower in the CoF-treated animals, suggesting that the E. coli-induced neutropenia was at least partially a complement-mediated response. In the CoF-treated monkeys, the initial rate of clearance of the E. coli from the circulation tended to be slower and the resultant levels of bacteremia were higher than in control animals. These observations are consistent with a hypothesis that complement-mediated neutrophilic leucocyte function is an important host defense mechanism in gram-ngeative bacillary bacteremia.

Full text

PDF
406

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ATHENS J. W., HAAB O. P., RAAB S. O., MAUER A. M., ASHENBRUCKER H., CARTWRIGHT G. E., WINTROBE M. M. Leukokinetic studies. IV. The total blood, circulating and marginal granulocyte pools and the granulocyte turnover rate in normal subjects. J Clin Invest. 1961 Jun;40:989–995. doi: 10.1172/JCI104338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. ATHENS J. W., RAAB S. O., HAAB O. P., MAUER A. M., ASHENBRUCKER H., CARTWRIGHT G. E., WINTROBE M. M. Leukokinetic studies. III. The distribution of granulocytes in the blood of normal subjects. J Clin Invest. 1961 Jan;40:159–164. doi: 10.1172/JCI104230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BENACERRAF B., SEBESTYEN M. M., SCHLOSSMAN S. A quantitative study of the kinetics of blood clearance of P32-labelled Escherichia coli and Staphylococci by the reticuloendothelial system. J Exp Med. 1959 Jul 1;110(1):27–48. doi: 10.1084/jem.110.1.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ballow M., Cochrane C. G. Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them. J Immunol. 1969 Nov;103(5):944–952. [PubMed] [Google Scholar]
  5. Berczi I., Bertók L., Bereznai T. Comparative studies on the toxicity of Escherichia coli lipopolysaccharide endotoxin in various animal species. Can J Microbiol. 1966 Oct;12(5):1070–1071. doi: 10.1139/m66-143. [DOI] [PubMed] [Google Scholar]
  6. Bladen H. A., Evans R. T., Mergenhagen S. E. Lesions in Escherichia coli membranes after action of antibody and complement. J Bacteriol. 1966 Jun;91(6):2377–2381. doi: 10.1128/jb.91.6.2377-2381.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bladen H. A., Gewurz H., Mergenhagen S. E. Interactions of the complement system with the surface and endotoxic lipopolysaccharide of Veillonella alcalescens. J Exp Med. 1967 May 1;125(5):767–786. doi: 10.1084/jem.125.5.767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cochrane C. G., Müller-Eberhard H. J., Aikin B. S. Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions. J Immunol. 1970 Jul;105(1):55–69. [PubMed] [Google Scholar]
  9. Day N. K., Good R. A., Finstad J., Johannsen R., Pickering R. J., Gewurz H. Interactions between endotoxic lipopolysaccharides and the complement system in the sera of lower vertebrates. Proc Soc Exp Biol Med. 1970 Apr;133(4):1397–1401. doi: 10.3181/00379727-133-34698. [DOI] [PubMed] [Google Scholar]
  10. Dinbar A., Rapaport S. I., Patch M. J., Grant W., Fonkalsrud E. W. Hematologic effects of endotoxin on the macaque monkey. Surgery. 1971 Oct;70(4):596–603. [PubMed] [Google Scholar]
  11. Dodds W. J., Pickering R. J. Purified cobra venom factor: effect on blood platelets. Proc Soc Exp Biol Med. 1972 Jun;140(2):429–434. doi: 10.3181/00379727-140-36473. [DOI] [PubMed] [Google Scholar]
  12. Fong J. S., Good R. A. Prevention of the localized and generalized Shwartzman reactions by an anticomplementary agent, cobra venom factor. J Exp Med. 1971 Sep 1;134(3 Pt 1):642–655. doi: 10.1084/jem.134.3.642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Füst G., Keresztes M. Effect of endotoxin on the serum level of complement components. II. Effect of endotoxin on dog serum complement level in vivo and in vitro. Acta Microbiol Acad Sci Hung. 1969;16(2):135–147. [PubMed] [Google Scholar]
  14. GILBERT R. P. Endotoxin shock in the primate. Proc Soc Exp Biol Med. 1962 Nov;111:328–331. doi: 10.3181/00379727-111-27781. [DOI] [PubMed] [Google Scholar]
  15. Gewurz H. Interaction between endotoxic lipopolysaccharides (LPS) and the complement (C) system: solubilization of C-consuming substances during brief absorbtions at 0 degrees. Proc Soc Exp Biol Med. 1971 Feb;136(2):561–564. doi: 10.3181/00379727-136-35311. [DOI] [PubMed] [Google Scholar]
  16. Gewurz H., Shin H. S., Mergenhagen S. E. Interactions of the complement system with endotoxic lipopolysaccharide: consumption of each of the six terminal complement components. J Exp Med. 1968 Nov 1;128(5):1049–1057. doi: 10.1084/jem.128.5.1049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Goodkofsky I., Lepow I. H. Functional relationship of factor B in the properdin system to C3 proactivator of human serum. J Immunol. 1971 Oct;107(4):1200–1204. [PubMed] [Google Scholar]
  18. Goodman J. S., Rogers D. E., Koenig M. G. The hepatic uptake of bacterial endotoxin. I. The influence of humoral and cellular factors. Proc Soc Exp Biol Med. 1969 Oct;132(1):372–375. doi: 10.3181/00379727-132-34217. [DOI] [PubMed] [Google Scholar]
  19. Green G. M., Goldstein E. A method for quantitating intrapulmonary bacterial inactivation in individual animals. J Lab Clin Med. 1966 Oct;68(4):669–677. [PubMed] [Google Scholar]
  20. Guenter C. A., Fiorica V., Hinshaw L. B. Cardiorespiratory and metabolic responses to liver E. coli and endotoxin in the monkey. J Appl Physiol. 1969 Jun;26(6):780–786. doi: 10.1152/jappl.1969.26.6.780. [DOI] [PubMed] [Google Scholar]
  21. Götze O., Müller-Eberhard H. J. The C3-activator system: an alternate pathway of complement activation. J Exp Med. 1971 Sep 1;134(3 Pt 2):90s–108s. [PubMed] [Google Scholar]
  22. HOWARD J. G., WARDLAW A. C. The opsonic effect of normal serum on the uptake of bacteria by the reticulo-endothelial system; perfusion studies with isolated rat liver. Immunology. 1958 Oct;1(4):338–352. [PMC free article] [PubMed] [Google Scholar]
  23. Hand W. L., Smith J. W., Sanford J. P. The antibacterial effect of normal and infected urinary bladder. J Lab Clin Med. 1971 Apr;77(4):605–615. [PubMed] [Google Scholar]
  24. Hinshaw L. B., Emerson T. E., Jr, Reins D. A. Cardiovascular responses of the primate in endotoxin shock. Am J Physiol. 1966 Feb;210(2):335–340. doi: 10.1152/ajplegacy.1966.210.2.335. [DOI] [PubMed] [Google Scholar]
  25. Hinshaw L. B., Solomon L. A., Holmes D. D., Greenfield L. J. Comparison of canine responses to Escherichia coli organisms and endotoxin. Surg Gynecol Obstet. 1968 Nov;127(5):981–988. [PubMed] [Google Scholar]
  26. Hook W. A., Snyderman R., Mergenhagen S. E. Consumption of hamster complement by bacterial endotoxin. J Immunol. 1970 Jul;105(1):268–270. [PubMed] [Google Scholar]
  27. Hook W. A., Snyderman R., Mergenhagen S. E. Histamine-releasing factor generated by the interaction of endotoxin with hamster serum. Infect Immun. 1970 Oct;2(4):462–467. doi: 10.1128/iai.2.4.462-467.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Jasin H. E. Human heat labile opsonins: evidence for their mediation via the alternate pathway of complement activation. J Immunol. 1972 Jul;109(1):26–31. [PubMed] [Google Scholar]
  29. Johnson F. R., Agnello V., Williams R. C., Jr Opsonic activity in human serum deficient in C2. J Immunol. 1972 Jul;109(1):141–145. [PubMed] [Google Scholar]
  30. KUIDA H., GILBERT R. P., HINSHAW L. B., BRUNSON J. G., VISSCHER M. B. Species differences in effect of gram-negative endotoxin on circulation. Am J Physiol. 1961 Jun;200:1197–1202. doi: 10.1152/ajplegacy.1961.200.6.1197. [DOI] [PubMed] [Google Scholar]
  31. Kwaan H. M., Weil M. H. Differences in the mechanism of shock caused by bacterial infections. Surg Gynecol Obstet. 1969 Jan;128(1):37–45. [PubMed] [Google Scholar]
  32. Lehmann J. D., Smith J. W., Miller T. E., Barnett J. A., Sanford J. P. Local immune response in experimental pyelonephritis. J Clin Invest. 1969 Nov;47(11):2541–2550. doi: 10.1172/JCI105936. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Lichtenstein L. M., Gewurz H., Adkinson N. F., Jr, Shin H. S., Mergenhagen S. E. Interactions of the complement system with endotoxic lipopolysaccharide: the generation of an anaphylatoxin. Immunology. 1969 Mar;16(3):327–336. [PMC free article] [PubMed] [Google Scholar]
  34. MECHANIC R. C., FREI E., 3rd, LANDY M., SMITH W. W. Quantitative studies of human leukocytic and febrile response to single and repeated doses of purified bacterial endotoxin. J Clin Invest. 1962 Jan;41:162–172. doi: 10.1172/JCI104459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. MacLean L. D., Mulligan W. G., McLean A. P., Duff J. H. Patterns of septic shock in man--a detailed study of 56 patients. Ann Surg. 1967 Oct;166(4):543–562. doi: 10.1097/00000658-196710000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Marcus R. L., Shin H. S., Mayer M. M. An alternate complement pathway: C-3 cleaving activity, not due to C4,2a, on endotoxic lipopolysaccharide after treatment with guinea pig serum; relation to properdin. Proc Natl Acad Sci U S A. 1971 Jun;68(6):1351–1354. doi: 10.1073/pnas.68.6.1351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Mergenhagen S. E., Snyderman R., Gewurz H., Shin H. S. Significance of complement to the mechanism of action of endotoxin. Curr Top Microbiol Immunol. 1969;50:37–77. doi: 10.1007/978-3-642-46169-9_2. [DOI] [PubMed] [Google Scholar]
  38. Müller-Eberhard H. J., Fjellström K. E. Isolation of the anticomplementary protein from cobra venom and its mode of action on C3. J Immunol. 1971 Dec;107(6):1666–1672. [PubMed] [Google Scholar]
  39. Nelson R. A., Jr A new concept of immunosuppression in hypersensitivity reactions and in transplantation immunity. Surv Ophthalmol. 1966 Aug;11(4):498–505. [PubMed] [Google Scholar]
  40. Petz L., Fudenberg H. H., Fink D. Immune adherence reactions of human erythrocytes sensitized with complement in vitro and in vivo. J Immunol. 1971 Dec;107(6):1714–1722. [PubMed] [Google Scholar]
  41. Pool J. L., Owen S. E., Meyers F. K., Coalson J. J., Holmes D. D., Guenter C. A., Hinshaw L. B. Response of the subhuman primate in gram-negative septicemia induced by live Escherichia coli. Surg Gynecol Obstet. 1971 Mar;132(3):469–477. [PubMed] [Google Scholar]
  42. ROGERS D. E. Host mechanisms which act to remove bacteria from the blood stream. Bacteriol Rev. 1960 Mar;24(1):50–66. doi: 10.1128/br.24.1.50-66.1960. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Roantree R. J., Rantz L. A. A STUDY OF THE RELATIONSHIP OF THE NORMAL BACTERICIDAL ACTIVITY OF HUMAN SERUM TO BACTERIAL INFECTION. J Clin Invest. 1960 Jan;39(1):72–81. doi: 10.1172/JCI104029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Ruddy S., Gigli I., Austen K. F. The complement system of man. I. N Engl J Med. 1972 Sep 7;287(10):489–495. doi: 10.1056/NEJM197209072871005. [DOI] [PubMed] [Google Scholar]
  45. SMITH M. R., PERRY W. D., BERRY J. W., WOOD W. B., Jr Surface phagocytosis in vivo. J Immunol. 1951 Jul;67(1):71–74. [PubMed] [Google Scholar]
  46. SPIEGELBERG H. L., MIESCHER P. A., BENACERRAF B. STUDIES ON THE ROLE OF COMPLEMENT IN THE IMMUNE CLEARANCE OF ESCHERICHIA COLI AND RAT ERYTHROCYTES BY THE RETICULOENDOTHELIAL SYSTEM IN MICE. J Immunol. 1963 May;90:751–759. [PubMed] [Google Scholar]
  47. SPINK W. W., DAVIS R. B., POTTER R., CHARTRAND S. THE INITIAL STAGE OF CANINE ENDOTOXIN SHOCK AS AN EXPRESSION OF ANAPHYLACTIC SHOCK: STUDIES ON COMPLEMENT TITERS AND PLASMA HISTAMINE CONCENTRATIONS. J Clin Invest. 1964 Apr;43:696–704. doi: 10.1172/JCI104954. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Sandberg A. L., Osler A. G. Dual pathways of complement interaction with guinea pig immunoglobulins. J Immunol. 1971 Nov;107(5):1268–1273. [PubMed] [Google Scholar]
  49. Sheagren J. N., Wolff S. M., Shulman N. R. Febrile and hematologic responses of rhesus monkeys to bacterial endotoxin. Am J Physiol. 1967 Apr;212(4):884–890. doi: 10.1152/ajplegacy.1967.212.4.884. [DOI] [PubMed] [Google Scholar]
  50. Shin H. S., Gewurz H., Snyderman R. Reaction of a cobra venom factor with guinea pig complement and generation of an activity chemotactic for polymorphonuclear leukocytes. Proc Soc Exp Biol Med. 1969 May;131(1):203–207. doi: 10.3181/00379727-131-33840. [DOI] [PubMed] [Google Scholar]
  51. Siegel J. H., Greenspan M., Del Guercio L. R. Abnormal vascular tone, defective oxygen transport and myocardial failure in human septic shock. Ann Surg. 1967 Apr;165(4):504–517. doi: 10.1097/00000658-196704000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Snyderman R., Gewurz H., Mergenhagen S. E. Interactions of the complement system with endotoxic lipopolysaccharide. Generation of a factor chemotactic for polymorphonuclear leukocytes. J Exp Med. 1968 Aug 1;128(2):259–275. doi: 10.1084/jem.128.2.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Snyderman R., Phillips J. K., Mergenhagen S. E. Biological activity of complement in vivo. Role of C5 in the accumulation of polymorphonuclear leukocytes in inflammatory exudates. J Exp Med. 1971 Nov 1;134(5):1131–1143. doi: 10.1084/jem.134.5.1131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Vosti K. L., Randall E. Sensitivity of serologically classified strains of escherichia coli of human origin to the serum bactericidal system. Am J Med Sci. 1970 Feb;259(2):114–119. doi: 10.1097/00000441-197002000-00005. [DOI] [PubMed] [Google Scholar]
  55. WAISBREN B. A. GRAM-NEGATIVE SHOCK AND ENDOTOXIN SHOCK. Am J Med. 1964 Jun;36:819–824. doi: 10.1016/0002-9343(64)90111-1. [DOI] [PubMed] [Google Scholar]
  56. WOOD W. B., Jr, SMITH M. R., PERRY W. D., BERRY J. W. Studies on the cellular immunology of acute bacteremia. I. Intravascular leucocytic reaction and surface phagocytosis. J Exp Med. 1951 Dec 1;94(6):521–534. doi: 10.1084/jem.94.6.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Winkelstein J. A., Shin H. S., Wood W. B., Jr Heat labile opsonins to Pneumococcus. 3. The participation of immunoglobulin and of the alternate pathway of C3 activation. J Immunol. 1972 Jun;108(6):1681–1689. [PubMed] [Google Scholar]
  58. van Loghem J. J., Borne AE von dem, van der Hart M., Peetom F. Immune adherence and blood cell destruction. Vox Sang. 1967 May;12(5):361–373. doi: 10.1111/j.1423-0410.1967.tb03366.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES